Teva Agrees to Pay $520M to Resolve Foreign-Bribery Claims
Generic drugmaker Teva Pharmaceutical Industries Ltd. has agreed to pay more than $283 million to resolve criminal charges and fines over bribes to government officials in Russia, Ukraine and Mexico, in violation of the Foreign Corrupt Practices Act, the U.S. Department of Justice announced Thursday.
This premium content is reserved for National Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now